Reminder ads give the name of the drug, but not its use. The assumption behind the reminder advertisements is that the public knows what the drug is for and does not need to be told. A recall announcement does not contain information about the risks of the drug because it does not discuss the condition being treated or the effectiveness of the drug. In other words, reminder ads avoid the need for the “fair balance” of information because they contain neither benefits nor risks – just the name of the drug, which serves as a “reminder” to consumers who are already familiar with it. These advertisements cannot explain - or even suggest -
what the drug does, what disease it treats, what the recommended dosage is, or how the drug works; however, they also should not include information about the risks of the drug. These advertisements must mention the brand name of the drug (if applicable) and its jewelry retouching service generic name. Due to character limits in search text ads, these tips are often applied. Here is an example of what a callback announcement would look like: Campaign_Management_–_Google_AdWords As mentioned above, this ad falls
under guidance for recall ads because it contains the brand name of the drug, but does not discuss the disease or condition it treats. If so, the “fair balance” would apply and the risks would need to be disclosed. This is obviously not possible, as it would be much longer than the standard character limits for text ads. It's important to note that the guidance on recall ads is not aimed solely at SEM efforts and is applicable to many forms of advertising. Space limitations The FDA has also issued guidance regarding “Internet/Social Media Platforms with Character Space Limitations.”